A few comings and goings before the Independence Day holiday in the US: → Pfizer has welcomed former State Street Global ...

Sanofi and Regeneron’s Dupixent has notched another indication in the EU, this time for a common lung disease, marking the ...

Flagship Pioneering, the sprawling life sciences investor and startup incubator, appears to be seeking more capital than ...

GSK is handing mRNA vaccine partner CureVac €400 million ($429 million) upfront to take over full rights to the influenza and ...

Transat­lantic biotech Bea­con Ther­a­peu­tics has raised $170 mil­lion to po­ten­tial­ly bring a rare oph­thal­mol­o­gy gene ...

Moderna’s long-running patent dispute with Pfizer and BioNTech intensified Tuesday after London’s High Court of Justice ...

Emer­gent BioSo­lu­tions scored more than $250 mil­lion in gov­ern­ment con­tract mod­i­fi­ca­tions for four med­ical ...

Geopolitical tensions and threats of decoupling have led to a steep decline in American companies’ confidence in working with ...

In a late-stage study, Johnson & Johnson and Legend Biotech's CAR-T therapy Carvykti improved survival in multiple myeloma ...

Moderna received a significant boost from the federal government, snagging a $176 million contract to help advance a bird flu ...

Check­point Ther­a­peu­tics is tak­ing a sec­ond shot at ap­proval for its an­ti-PD-L1 can­di­date af­ter the FDA re­ject­ed ...